Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez

Showing results (41-50 of 183) with videos related to

Pageof 19
Sort By:
JAMA Oncology|October 17, 2018
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-ReplyInmaculada Hernandez, Vinay Prasad, Walid F Gellad
JAMA Dermatology|August 14, 2020
Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical CompaniesLaura K Ferris, Walid F Gellad, Inmaculada Hernandez
American Journal of Pharmaceutical Education|June 6, 2018
Teaching About the Health Care Industry Through GamificationCollin Wolf, Samuel Bott, Inmaculada Hernandez, et al.
JAMA Internal Medicine|March 10, 2020
The Skyrocketing Cost of Rectal IndomethacinB Joseph Elmunzer, Inmaculada Hernandez, Walid F Gellad
Journal of Health Politics, Policy and Law|July 22, 2022
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i LoopholeSean Dickson, Nico Gabriel, Walid Gellad, et al.
JAMA|September 8, 2018
Lowering the P Value ThresholdInmaculada Hernandez, Walid F Gellad, Chester B Good
JAMA|August 26, 2020
Drug Shortages and Group Purchasing Organizations-ReplyJulie M Donohue, Inmaculada Hernandez, Tina Batra Hershey
Journal of General Internal Medicine|July 14, 2021
The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug PatentDavid Miller, Benedic Ippolito, Inmaculada Hernandez, et al.
JAMA|March 4, 2020
Drug Shortages in the United States: Are Some Prices Too Low?Inmaculada Hernandez, Tina Batra Hershey, Julie M Donohue
American Journal of Alzheimer'S Disease and Other Dementias|May 9, 2020
Risk Factors for Cardiovascular Events in Patients on Antidementia MedicationsMeiqi He, James M Stevenson, Yuting Zhang, et al.
Pageof 19

Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
JAMA Oncology|October 17, 2018
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-ReplyInmaculada Hernandez, Vinay Prasad, Walid F Gellad
JAMA Dermatology|August 14, 2020
Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical CompaniesLaura K Ferris, Walid F Gellad, Inmaculada Hernandez
American Journal of Pharmaceutical Education|June 6, 2018
Teaching About the Health Care Industry Through GamificationCollin Wolf, Samuel Bott, Inmaculada Hernandez, et al.
JAMA Internal Medicine|March 10, 2020
The Skyrocketing Cost of Rectal IndomethacinB Joseph Elmunzer, Inmaculada Hernandez, Walid F Gellad
Journal of Health Politics, Policy and Law|July 22, 2022
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i LoopholeSean Dickson, Nico Gabriel, Walid Gellad, et al.
JAMA|September 8, 2018
Lowering the P Value ThresholdInmaculada Hernandez, Walid F Gellad, Chester B Good
JAMA|August 26, 2020
Drug Shortages and Group Purchasing Organizations-ReplyJulie M Donohue, Inmaculada Hernandez, Tina Batra Hershey
Journal of General Internal Medicine|July 14, 2021
The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug PatentDavid Miller, Benedic Ippolito, Inmaculada Hernandez, et al.
JAMA|March 4, 2020
Drug Shortages in the United States: Are Some Prices Too Low?Inmaculada Hernandez, Tina Batra Hershey, Julie M Donohue
American Journal of Alzheimer'S Disease and Other Dementias|May 9, 2020
Risk Factors for Cardiovascular Events in Patients on Antidementia MedicationsMeiqi He, James M Stevenson, Yuting Zhang, et al.
Pageof 19